Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cyclezyme ABXSAT:CYCLE -6.21%6 3-1 Month Momentum % is 96.79% as of Sep. 17, 2026. GuruFocus rates XSAT:CYCLE with a GF Score™ of 6/100. The stock has 2 warning signs investors should review. Among 1,623 Chemicals companies, Cyclezyme AB ranks better than 99.63% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-17), Cyclezyme AB's 3-1 Month Momentum % is 96.79%.
The industry rank for Cyclezyme AB's 3-1 Month Momentum % or its related term are showing as below:
XSAT:CYCLE's 3-1 Month Momentum % is ranked better than 99.63% of 1623
companies
in the Chemicals industry
Industry Median: -2.63
vs XSAT:CYCLE: 96.79
Cyclezyme AB (XSAT:CYCLE) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Cyclezyme AB 3-1 Month Momentum % Related Terms
XSAT:CYCLE vs LIN, SHW, ECL: 3-1 Month Momentum % Comparison
For the Specialty Chemicals subindustry, Cyclezyme AB's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyclezyme AB 3-1 Month Momentum % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cyclezyme AB's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Cyclezyme AB's 3-1 Month Momentum % falls into.
Cyclezyme AB (XSAT:CYCLE) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cyclezyme AB (XSAT:CYCLE) has a 3-1 Month Momentum % of 96.79% as of Sep. 17, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Cyclezyme AB and its competitors. According to the industry distribution chart, Cyclezyme AB ranks #6 out of 1623 companies in the Chemicals industry, placing it in the top 0.40000000000001%.
Is Cyclezyme AB's 3-1 Month Momentum % too high?
Cyclezyme AB's current 3-1 Month Momentum % is 96.79%. Based on the distribution chart, Cyclezyme AB ranks #6 out of 1623 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Cyclezyme AB has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Cyclezyme AB's 3-1 Month Momentum % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Cyclezyme AB ranks #6 out of 1623 companies for 3-1 Month Momentum %. This places Cyclezyme AB in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Chemicals company?
A good 3-1 Month Momentum % depends on the Chemicals industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Cyclezyme AB and its competitors. Cyclezyme AB's current 3-1 Month Momentum % is 96.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclezyme AB stock overvalued right now?
Cyclezyme AB (XSAT:CYCLE) has a current 3-1 Month Momentum % of 96.79%. The current 3-1 Month Momentum % is 96.79%. Cyclezyme AB's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Cyclezyme AB (XSAT:CYCLE), the current 3-1 Month Momentum % is 96.79% as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
6GF Score
Get the complete analysis for XSAT:CYCLE
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:CYCLE has been successfully added to your 
